ACE2 and COVID-19: Given that we found negligible expression of ACE2 in non-COVID-19 lungs irrespective of gender, and a uniform increase in ACE2 expression in all severe COVID-19 lungs, it seems unlikely that baseline pulmonary ACE2 expression levels contribute to the risk of developing COVID-19 pulmonary disease in infected patients.